Skip to content
The Nexus
BUSINESSAug 5 · 11:20 UTCQUARTZCris Tolomia

CVS Health's profit nearly tripled as it launched an Eli Lilly weight loss drug deal

CVS Health's profit nearly tripled in the second quarter, beating Wall Street expectations. The company raised its full-year profit forecast to as much as $8.10 per share due to a weight loss drug deal with Eli Lilly.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
CVS HealthorganizationEli Lillyorganizationweight loss drug dealtopicWall Streettopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting